Clinical Trials Browser

Phase 1/2 × Colorectal Neoplasms × tremelimumab × Clear all

NCT03206073 2023-10-24

A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in Refractory Colorectal Cancer

Phase 1/2 Completed

34 enrolled 18 charts

Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT03202758 2023-02-10

MEDITREME

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms